Overview
Ciliopathies are a broad group of rare genetic disorders caused by defects in the structure or function of cilia — tiny hair-like projections found on the surface of nearly all human cells. Cilia play critical roles in cell signaling, fluid movement, and organ development. Because cilia are present in virtually every tissue, ciliopathies can affect multiple organ systems including the kidneys, eyes, brain, liver, skeleton, and respiratory tract. The Orphanet grouping under code 363250 represents ciliopathy as an overarching disease category encompassing numerous specific conditions such as Bardet-Biedl syndrome, Joubert syndrome, Meckel syndrome, nephronophthisis, primary ciliary dyskinesia, and polycystic kidney disease, among others. Key clinical features vary widely depending on the specific ciliopathy but commonly include renal cystic disease, retinal degeneration (retinitis pigmentosa), cerebellar malformations, polydactyly, obesity, intellectual disability, hepatic fibrosis, situs inversus, and chronic respiratory infections. Many ciliopathies present with overlapping phenotypes, making clinical diagnosis challenging. Onset ranges from prenatal or neonatal life (as in lethal forms like Meckel syndrome) to adulthood (as in some forms of polycystic kidney disease). Treatment for ciliopathies is currently largely supportive and symptom-based, as no curative therapies exist for most forms. Management may include renal replacement therapy or transplantation for kidney disease, respiratory physiotherapy for primary ciliary dyskinesia, surgical correction of skeletal anomalies, and visual aids or rehabilitation for retinal degeneration. Emerging research into gene therapy and targeted molecular treatments offers hope for future disease-modifying interventions. Multidisciplinary care involving nephrology, ophthalmology, neurology, pulmonology, and genetics is essential for optimal patient outcomes.
Variable
Can be inherited in different ways depending on the underlying gene
Variable
Can begin at different ages, from infancy through adulthood
FDA & Trial Timeline
3 eventsOhio State University — NA
Peking University First Hospital
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Ciliopathy.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Ciliopathy at this time.
New trials open frequently. Follow this disease to get notified.
Rare Disease Specialist
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Ciliopathy.
Community
No community posts yet. Be the first to share your experience with Ciliopathy.
Start the conversation →Latest news about Ciliopathy
Disease timeline:
New recruiting trial: Utility of PCD Diagnostics to Improve Clinical Care
A new clinical trial is recruiting patients for Ciliopathy
New recruiting trial: Use of Nasal Nitric Oxide Testing in Improving Primary Ciliary Dyskinesia Clinical Care
A new clinical trial is recruiting patients for Ciliopathy
New recruiting trial: PKD Clinical and Translational Core Study
A new clinical trial is recruiting patients for Ciliopathy
New recruiting trial: A Qualitative Study Investigating the Lived Experiences and Impact of Reproductive Issues in Adults With Primary Ciliary Dyskinesia
A new clinical trial is recruiting patients for Ciliopathy
New recruiting trial: Living With Primary Ciliary Dyskinesia (Living With PCD)
A new clinical trial is recruiting patients for Ciliopathy
New recruiting trial: DCP (RaDiCo Cohort) (RaDiCo-DCP)
A new clinical trial is recruiting patients for Ciliopathy
New recruiting trial: Utility of PCD Diagnostics to Improve Clinical Care
A new clinical trial is recruiting patients for Ciliopathy
New recruiting trial: Well-Formulated Ketogenic Diet Polycystic Kidney Disease
A new clinical trial is recruiting patients for Ciliopathy
New recruiting trial: Thermal Spa Treatment and Improvement of Primary Ciliary Dyskinesia
A new clinical trial is recruiting patients for Ciliopathy
New recruiting trial: International Primary Ciliary Dyskinesia (PCD) Registry
A new clinical trial is recruiting patients for Ciliopathy
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Ciliopathy
What is Ciliopathy?
Ciliopathies are a broad group of rare genetic disorders caused by defects in the structure or function of cilia — tiny hair-like projections found on the surface of nearly all human cells. Cilia play critical roles in cell signaling, fluid movement, and organ development. Because cilia are present in virtually every tissue, ciliopathies can affect multiple organ systems including the kidneys, eyes, brain, liver, skeleton, and respiratory tract. The Orphanet grouping under code 363250 represents ciliopathy as an overarching disease category encompassing numerous specific conditions such as Bar
Which specialists treat Ciliopathy?
24 specialists and care centers treating Ciliopathy are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.